Moderna Drops 11%, ImmunityBio Slide Wakes Biotech Rout
Biotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Looking to access your cash quickly? Explore ways to retrieve cash fast and solve your financial needs.
20,518 articlesBiotech shares retreat as Moderna slides 11% and ImmunityBio falls, with Sarepta also sinking amid a broad market rot...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
As chip stocks wobble, there are three AI-focused names that still stand out to me. This guide explains why they matt...
Jim Cramer signals resilience in the AI-security wave, underscoring a ongoing hunt for the next DeepSeek. Here are fi...
A big earnings event could flip the script for Microsoft stock. This article breaks down why the bold idea of a parab...
Thinking about retiring in your 40s? The FIRE movement offers a practical path to financial independence through aggr...
A surge in crypto funding surging again accompanies a strategic pivot by major VCs toward infrastructure and tokenize...
TD Bank has been on investors' radars, but sustained upside hinges on three core drivers. Explore how regulatory shif...
Visa faces a mix of growth drivers and risks as digital payments expand globally. This piece outlines the visa stock ...
Avantis U.S. Small Cap Value ETF relies on a profitability filter that separates it from ordinary small-cap funds, ai...
Four high-profile tech names have shed 23% to 37% in 2026 as the Nasdaq edges higher. Analysts see substantial upside...
A former lululemon executive voices governance concerns, highlighting how board independence, capital allocation, and...